Ulta Beauty has named Christopher DelOrefice the company’s new chief financial officer.

DelOrefice will begin his new role on Dec. 5, and Chris Lialios will continue to serve as interim chief financial officer in the meantime.

Kecia Steelman, president and CEO, said his demonstrated experience leading core finance functions, global operations, strategy, corporate development and enterprise transformation for public companies will be a great partner to the team as the company continues to execute its Ulta Beauty Unleashed strategy and deliver long-term value for stakeholders.

Tenures at Becton Dickinson & Company & Beyond

DelOrefice is an experienced business leader who has led global, cross-functional teams at companies that have delivered superior financial performance. He joins Ulta Beauty from Becton Dickinson & Company, where he has served as executive vice president and chief financial officer since September 2021. Prior to Becton Dickinson, DelOrefice spent more than 20 years with Johnson & Johnson, a multinational pharmaceutical, biotechnology and medical technologies company, and held financial leadership roles of increasing responsibility including as vice president, investor relations, vice president finance and CFO, North America Hospital Medical Devices, and vice president finance and CFO, North America Consumer.

Earlier in his career, he held leadership positions in accounting, financial reporting, global audit and supply chain finance at Astra Zeneca Pharmaceuticals, AET Films, Inc. and Ametek, Inc. DelOrefice is a certified public accountant (inactive) and holds both a BS in accounting and an MBA from Villanova University. DelOrefice serves on the Board of Directors for ResMed and serves as the Chair of ResMed’s audit committee.